terazosin
NDC 23155-736, terazosin, capsule, from Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
- Product NDC
- 23155-736
- Status
- Listed
- Labeler
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075614
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/23155-736 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE2 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 23155-736-01 | 23155073601 | 100 CAPSULE in 1 BOTTLE (23155-736-01) |
| 23155-736-10 | 23155073610 | 1000 CAPSULE in 1 BOTTLE (23155-736-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/1dabd4d6-3023-460a-8577-08b3690e7c93NADAC price for package 23155073601
GET /v1/drugs/nadac/23155073601NADAC price for package 23155073610
GET /v1/drugs/nadac/23155073610
Use it
Look up 23155-736 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/23155-736 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 23155-736. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.